Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Matthew Rettig
C-CRK Proto-Oncogene Contributes to Transcriptional Repression of P120-Catenin in Non-Small Cell Lung Cancer Cells
Clinical and Experimental Metastasis
Medicine
Cancer Research
Oncology
Related publications
Repression of lncRNA-SVUGP2 Mediated by EZH2 Contributes to the Development of Non-Small Cell Lung Cancer via Brisking WNT/Β-Catenin Signal
Artificial Cells, Nanomedicine and Biotechnology
Medicine
Biotechnology
Biomedical Engineering
Pharmaceutical Science
Management of Leptomeningeal Metastases in Non-Oncogene Addicted Non-Small Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
Changes in the Phenotype of Human Small Cell Lung Cancer Cell Lines After Transfection and Expression of the C-Myc Proto-Oncogene.
Journal of Clinical Investigation
Medicine
When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?
Current Treatment Options in Oncology
Oncology
Pharmacology
P3.13-04 Lorlatinib in Anaplastic Lymphoma Kinase and Proto-Oncogene Tyrosine-Protein Kinase ROS-Positive Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
TopBP1 Contributes to the Chemoresistance in Non-Small Cell Lung Cancer Through Upregulation of P53
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
ALKBH3, a Human AlkB Homologue, Contributes to Cell Survival in Human Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Antagonism Between HtrA3 and TGF-β1 Contributes to Metastasis in Non-Small-Cell Lung Cancer
Cancer Research
Cancer Research
Oncology
The Parafibromin Tumor Suppressor Protein Inhibits Cell Proliferation by Repression of the C-Myc Proto-Oncogene
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
